SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Elan Corporation, plc (ELN)
An SI Board Since October 1996
Posts SubjectMarks Bans Symbol
10345 171 0 ELN
Emcee:  Harold Engstrom Type:  Moderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
10170Time for Harold to change the thread description.Qualified Opinion-7/2/2009
10169I wouldn't use the word unaffected at all. How many alzheimer's researchQualified Opinion-7/2/2009
10168Yes for the programs partnered with Wyeth. A disappointment to say the least. Gofred hayes17/2/2009
10167Elan's interest in alzheimer's seems to drop to approximately 25% plus aQualified Opinion-7/2/2009
10166J&J will be paying 50% R&D cost (up to 500 mill), WYE owns and pay the oLee39-7/2/2009
10165$1B gets 50.1% of Alz program plus 18.4% of Elan company. ----------------------kenhott-7/2/2009
10164Ok, the past few weeks was just chatter. reuters.com <b>J&J buys $1 Biotech Jim-7/2/2009
10163Novartis Reportedly In Talks To Buy Certain Operations Of Elan 6/29/2009 2:24 Asim116/29/2009
10162And yet another posted today. And, you guessed it, from outside the US. That'fred hayes-6/26/2009
10161Hughh?Robohogs-6/22/2009
10160OT: Congrats to SI Bob -- in case you missed it, see the message on top under thfred hayes-6/22/2009
10159One more reported friday -- total of 9, 7 outside the US. Starting to look like fred hayes-6/22/2009
10158Sure took them a long time to confirm this case..... NEW YORK (Dow Jones)--BiogArthur Radley-6/15/2009
10157reuters.com Fingers are crossed that this time they can get a deal done....Arthur Radley-6/10/2009
10156In my opinion Elan won't run out of money. They have over two years before Lance Bredvold-6/4/2009
10155What happens when Elan runs out of money?steve kammerer-6/4/2009
10154reuters.com Options seem to be limited........as for potential partnership dealArthur Radley-6/3/2009
10153Elan, Bristol-Myers talks broke down-source Reuters, Tuesday June 2 2009 * Talsim1-6/3/2009
10152Elan Is Holding M&A Talks With Bristol-Myers—WSJ: siliconinvestor.comDewDiligence_on_SI-5/29/2009
10151NEW YORK (AP) -- A Barclays Capital analyst upgraded shares of Biogen Idec Inc. Arthur Radley-5/20/2009
10150Current market conditions.... Define your terms, Gotzsche, define your terms! tom pope-5/13/2009
10149Head fake or the truth.........comment by CEO today. "** Danish pharmaceutArthur Radley-5/13/2009
10148Overall market down today, but once again ELN has nearly double normal trading vArthur Radley-5/7/2009
10147Copaxone Continues to Clean Tysabri’s Clock in US Market: siliconinvestor.comDewDiligence_on_SI-5/5/2009
10146and the discussions could go on for the next 3-6 months. One has to consider thBiotech Jim15/5/2009
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News